Pretax income is the income that a company earns before paying income taxes. Telesis Bio's pretax income for the
three
months ended in Dec. 2023 was $-17.68 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-47.70 Mil.
Telesis Bio's pretax margin was -253.46%.
During the past 5 years, Telesis Bio's highest Pretax Margin was -173.40%. The lowest was -352.66%. And the median was -225.20%.
Telesis Bio Pre-Tax Income Historical Data
The historical data trend for Telesis Bio's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Telesis Bio's Pre-Tax Income
For the Medical Devices subindustry, Telesis Bio's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Telesis Bio's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Telesis Bio's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Telesis Bio's Pre-Tax Income falls into.
Telesis Bio Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Telesis Bio's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-47.70 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Telesis Bio (NAS:TBIO) Pre-Tax Income Explanation
Telesis Bio's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 5 years, Telesis Bio's highest Pretax Margin was -173.40%. The lowest was -352.66%. And the median was -225.20%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Telesis Bio Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Telesis Bio's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Telesis Bio Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services. Its products comprise of BioXp system, BioXp kits, Benchtop reagents, Coronavirus tools, and BioXp biofoundry services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TBIO has been successfully added to your 